Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ZNF571 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TNFRSF10C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
COPS4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBM41 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SGCA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNX8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
GEO DataSets Gene Profile neighbors
RARA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM176A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BUB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A48 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRT32 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC13A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAP30 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHRM5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on